FDA Approves Nuplazid for Parkinson’s Hallucinations
Half of patients with Parkinson's may experience hallucinations, delusions
April 2016 Briefing – Internal Medicine
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for April 2016. This roundup includes the...
Exenatide Reduces Liver Fat in Type 2 Diabetes With Obesity
Reduction in epicardial adipose tissue and liver fat content with exenatide versus reference treatment
Delirium Predicts Function in Elderly After Aortic Valve Surgery
Effects of delirium seen in short-term, but not long-term, activity of daily living functioning
Patients Often Dissatisfied With Acne Care
Patients dissatisfied with acne management approaches, find GPs lacking information
Updated Recs Aim to Expand Primary Aldosteronism Screening
Revised guidelines update recommendations from Endocrine Society's 2008 guidelines
Markers That Predict Omalizumab Response Identified
Baseline periostin level, free IgE during treatment follow-up tied to asthma exacerbations
2017 May Offer Fewer Choices for Affordable Care Act Enrollees
UnitedHealth's exit from most marketplaces highlights health exchanges' growing pains
Acute Diverticulitis No Worse in Younger Patients
They have more severe CT presentation and readmissions but not worse disease course
Dietary Choices Appear to Impact Microbial Diversity of Gut
Findings from two separate studies
